Arcus Biosciences, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
RCUS on NYSE
Industry
Pharmaceutical Preparations
Location
3928 Point Eden Way, Hayward, CA

Insiders trading volume in the past year

Arcus Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gilead Sciences, Inc. 10%+ Owner $346M +$15M +4.54% Feb 18, 2025
Juan C. Jaen President $31M -$5.16M -14.3% Dec 4, 2025
Terry J. Rosen Chief Executive Officer, Director $26M +$201K +0.78% Feb 27, 2025
Yasunori Kaneko Director $7.73M +$201K +2.67% Jun 10, 2025
Jennifer Jarrett Chief Operating Officer $4.16M -$1.7M -29% Nov 7, 2025
Robert Goeltz II Chief Financial Officer $2.18M -$279K -11.3% Nov 26, 2025
Carolyn Tang General Counsel $2.06M Jan 23, 2025
Dimitry SA Nuyten Chief Medical Officer $1.41M Dec 15, 2024
Kathryn E. Falberg Director $1.39M Jun 10, 2025
Richard Markus Chief Medical Officer $1.13M Feb 10, 2025
Alexander Azoy Chief Accounting Officer $711K -$105K -12.9% Nov 26, 2025
David L. Lacey Director $576K Jun 10, 2025
Antoni Ribas Director $424K Jun 10, 2025
William Grossman Chief Medical Officer $414K Jun 16, 2021
Andrew J. Perlman Director $346K Jun 10, 2025
Patrick Machado Director $313K Jun 10, 2025
Nicole Lambert Director $303K Jun 10, 2025
Dietmar Berger Director $0 Feb 6, 2025
Johanna Mercier Director $0 Jan 29, 2024
Linda Slanec Higgins Director Aug 10, 2021

Recent Insider Transactions by Companies or Individuals for Arcus Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.